Press release
Global CDK and Inhibitor Drug Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028
The Global CDK and Inhibitor Drug Market is anticipated to grow at a significant CAGR of 12.6% during the forecast period (2022-2028). CDK stands for cyclin-dependent kinase, and it is a crucial enzyme in cell division. CDK4/6 inhibitors block signals that promote malignant (cancerous) cell proliferation. One of the primary factors driving the growth of the CDK inhibitor drug market is the rising prevalence of cancer. Another reason for this market's strong growth is the presence of a robust clinical pipeline due to increased demand for novel medications and therapies. Cancer has a high unmet medical need since it is a lethal disease that affects a huge population. The market is driven by patient's expectations for advanced cancer treatment medicine.The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance,
• In December 2021, ARV-471, a novel PROTAC oestrogen receptor (ER) degrader being co-developed by Arvinas, Inc. and Pfizer Inc., has received an update on Phase-1 dose-escalation data. ARV-471 is being co-developed for the treatment of patients with locally advanced or metastatic ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer (ER).
• In November 2021, Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new cancer cell biology treatments, announced the dosing of the first patient in its multi-cohort Phase-1/2 study of oral fadraciclib in patients with myelodysplastic syndromes (MDS).
• In October 2021, The USFDA approved abemaciclib in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score of less than 20%, as determined by the USFDA.
• In August 2020, ARC Therapeutics, a development-stage pharmaceutical business focused on creating small molecule inhibitors of cyclin-dependent kinases (CDKs) for the treatment of advanced and resistant malignancies, has raised $6 million from initial investor Eshelman Ventures LLC.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global CDK and Inhibitor Drug Market at:
https://orionmarketreports.com/request-sample/?id=102631&submit=Request+Sample%0D%0A
Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape- Pfizer Inc., Novartis International AG, Eli Lilly and Company, Astex Pharmaceuticals, and Sanofi S.A., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
A full report of Global CDK and Inhibitor Drug Market is available at:
https://orionmarketreports.com/global-cdk-and-inhibitor-drug-market/102631/
Global CDK and Inhibitor Drug Market Report by Segment
By Type
• Palbociclib
• Ribociclib
• Abemaciclib
By Distribution Channel
• Hospital Pharmacies
• Online Pharmacies
• Others
Global CDK and Inhibitor Drug Market Report by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global CDK and Inhibitor Drug Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028 here
News-ID: 2611726 • Views: …
More Releases from Orion Market Reports
Sodium Cromoglicate API Market to Expand With Strong Development by 2031
The Sodium Cromoglicate API Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Sodium Cromoglicate API (active pharmaceutical ingredient) is a type of medication used to treat allergic conditions such as hay fever, allergic conjunctivitis, and asthma. It works by stabilizing mast cells and preventing the release of allergic substances that cause symptoms like itching, redness, and swelling.
Sodium Cromoglicate API Market…
Soda Ash and Aluminium Trihydrate (ATH) Market Will Generate Record Revenue by 2 …
The Soda Ash and Aluminium Trihydrate (ATH) Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Soda Ash, also known as sodium carbonate, is a white, odorless powder used in manufacturing glass, detergents, chemicals, and other industrial applications. Aluminium Trihydrate (ATH) is a white, non-toxic powder primarily used as a flame retardant in plastics, rubber, and textiles.
Soda Ash and Aluminium Trihydrate…
Single Crystal Silicon Wafers Market Provides Information on Historical Growth, …
The Single Crystal Silicon Wafers Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Single crystal silicon wafers are thin, disc-shaped substrates made from a single crystal of silicon. They are a fundamental component in the semiconductor industry and serve as the foundation for manufacturing integrated circuits (ICs) and other microelectronic devices.
Single Crystal Silicon Wafers Market research analyzes the entire market,…
Silicone For Personal Care Market Growth Drivers, Developments, Technology And F …
The Silicone For Personal Care Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Silicone for personal care refers to the use of silicone-based ingredients and formulations in various cosmetic and personal care products. Silicone compounds are valued in the personal care industry for their unique properties, including their smooth texture, excellent spreadability, water resistance, film-forming ability, and compatibility with skin…
More Releases for CDK
Investigation ongoing for Investors in CDK Global, Inc. (NASDAQ: CDK) over poten …
An investigation on behalf of investors in shares of CDK Global, Inc. (NASDAQ: CDK) was announced over potential breaches of fiduciary duties by certain officers and directors at CDK Global, Inc.
Investors who purchased shares of CDK Global, Inc. (NASDAQ: CDK) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain CDK Global, Inc. directors breached…
Cancer CDK Inhibitors Market 2021 | Detailed Report
According to Market Study Report, Cancer CDK Inhibitors Market provides a comprehensive analysis of the Cancer CDK Inhibitors Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Cancer CDK Inhibitors Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5087783
The report provides a…
CDK Websites See Significant Organic Traffic Increases
REUNION MARKETING
Data Beats Intuition
418 S. Dawson St.
Raleigh, North Carolina 27601
NEWS RELEASE
For Immediate Release
CDK Websites See Significant Organic Traffic Increases
The Recent Google Algorithm Affected Traffic Flows Across CMSs
August 20, 2018 — Reunion Marketing personnel noted a remarkable increase in organic traffic for CDK websites that directly coincides with a Google algorithm update.
While conducting regular audits, members of the Reunion team discovered a pattern of significant increases in organic website traffic throughout…
Dealer Management Market Excellent Growth | IBM, CA, Cox Automotive, CDK Global
The qualitative research study conducted by HTF MI titled “Global Dealer Management Market Size, Status and Forecast 2025” provides primary Data, surveys, Scope of the Product and vendor briefings. The market dynamic forces have been determined after conducting a detailed study of the Global Dealer Managementmarket. The study provides forecasts for Dealer Management investments till 2022.
If you are involved in the Dealer Management industry or intend to be, then…
Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022 Report
“Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022” report highlights:
* Selectivity and Working Mechanism of a Cancer CDKs Inhibitor
* Recent Advances in the CDKs Related Cancer Therapy
* Global Cancer CDK Inhibitors Clinical Trials Insight: 45 Drugs in Pipeline
* Market Opportunity Assessment: More Than US$ 20 Billion (2022)
* Price Analysis of Cancer CDKs Inhibitors:
* Sales Analysis of Available Drugs: More Than US$ 2 Billion (2017)
Download Report Sample Weblink:…
Download Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022
“Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022” report gives comprehensive insight on clinical and non-clinical parameters related to emergence and growth of CDK inhibitors in cancer therapy. As per report findings, CDK inhibitors have emerged as new growth frontier for the organizations involved in the research, development, licensing and commercialization of targeted cancer therapies. There are 2 CDK inhibitors commercially available in the market for the treatment…
